Naomi Allen
BSc, MSc, DPhil
Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is a Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She joined UK Biobank as Senior Epidemiologist in 2011, and became Chief Scientist in 2019, where she is responsible for following-up participants both through linkage with routine health-related datasets, and through web-based questionnaires. She is also involved in developing the scientific strategy for future enhancements for the study. Her research interest is largely in the role of diet, obesity and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world.
Recent publications
-
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer.
Cooley V. et al, (2025), International journal of cancer
-
Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank.
Camm CF. et al, (2025), Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 27
-
UK Biobank-A Unique Resource for Discovery and Translation Research on Genetics and Neurologic Disease.
Taylor H. et al, (2025), Neurology. Genetics, 11
-
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection.
Duff EP. et al, (2025), Nature medicine
-
Convolutional neural network-based classification of glaucoma using optic radiation tissue properties
Kruper J. et al, (2024), Communications Medicine, 4